PULMATRIX, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
PULMATRIX, INC. (PULM) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $2.00 thousand for the 3-month period ending 2026-06-30, per its S-4/A filed 2026-09-17.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-09-17
- PULMATRIX, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $2.00K, a 66.67% decline year-over-year.
- PULMATRIX, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $3.00K, a 62.50% decline year-over-year.
- PULMATRIX, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $6.00K, a 96.95% decline year-over-year.
- PULMATRIX, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $6.00K, a 94.17% decline year-over-year.
- PULMATRIX, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $954.00K, a 14.36% decline from fiscal 2022.
- PULMATRIX, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $1.11M, a 3.80% decline from fiscal 2021.
- PULMATRIX, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2021 was $1.16M, a 0.00% change from fiscal 2020.
- PULMATRIX, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2020 was $1.16M, a 43.95% decline from fiscal 2019.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.00K S-4/A · filed 2026-09-17 | $5.00K derived: sum of 2 quarters · filed 2026-09-17 | ||
| 2026-03-31 | $3.00K S-4/A · filed 2026-09-17 | |||
| 2025-12-31 | $25.00K S-4/A · filed 2026-09-17 | |||
| 2025-09-30 | $6.00K 10-Q · filed 2025-10-16 | $12.00K derived: sum of 2 quarters · filed 2026-09-17 | $20.00K derived: sum of 3 quarters · filed 2026-09-17 | |
| 2025-06-30 | $6.00K S-4/A · filed 2026-09-17 | $14.00K derived: sum of 2 quarters · filed 2026-09-17 | ||
| 2025-03-31 | $8.00K S-4/A · filed 2026-09-17 | |||
| 2024-12-31 | $511.00K S-4/A · filed 2026-09-17 | |||
| 2024-09-30 | $197.00K 10-Q · filed 2025-10-16 | $300.00K derived: sum of 2 quarters · filed 2025-10-16 | $498.00K derived: sum of 3 quarters · filed 2025-10-16 | |
| 2024-06-30 | $103.00K 10-Q · filed 2025-10-16 | $301.00K derived: sum of 2 quarters · filed 2025-10-16 | ||
| 2024-03-31 | $198.00K 10-Q · filed 2025-10-16 | |||
| 2023-12-31 | $954.00K 10-K · filed 2025-03-21 | |||
| 2023-09-30 | $206.00K 10-Q · filed 2024-11-08 | $461.00K derived: sum of 2 quarters · filed 2024-11-08 | $757.00K derived: sum of 3 quarters · filed 2024-11-08 | |
| 2023-06-30 | $255.00K 10-Q · filed 2024-11-08 | $551.00K derived: sum of 2 quarters · filed 2024-11-08 | ||
| 2023-03-31 | $296.00K 10-Q · filed 2024-11-08 | |||
| 2022-12-31 | $1.11M 10-K · filed 2024-03-28 | |||
| 2022-09-30 | $277.00K 10-Q · filed 2023-11-09 | $554.00K derived: sum of 2 quarters · filed 2023-11-09 | $835.00K derived: sum of 3 quarters · filed 2023-11-09 | |
| 2022-06-30 | $277.00K 10-Q · filed 2023-11-09 | $558.00K derived: sum of 2 quarters · filed 2023-11-09 | ||
| 2022-03-31 | $281.00K 10-Q · filed 2023-11-09 | |||
| 2021-12-31 | $1.16M 10-K · filed 2023-03-30 | |||
| 2021-09-30 | $284.00K 10-Q · filed 2022-11-10 | $583.00K derived: sum of 2 quarters · filed 2022-11-10 | $911.00K derived: sum of 3 quarters · filed 2022-11-10 | |
| 2021-06-30 | $299.00K 10-Q · filed 2022-11-10 | $627.00K derived: sum of 2 quarters · filed 2022-11-10 | ||
| 2021-03-31 | $328.00K 10-Q · filed 2022-11-10 | |||
| 2020-12-31 | $1.16M 10-K · filed 2022-03-29 | |||
| 2020-09-30 | $303.00K 10-Q · filed 2021-11-10 | $569.00K derived: sum of 2 quarters · filed 2021-11-10 | $912.00K derived: sum of 3 quarters · filed 2021-11-10 | |
| 2020-06-30 | $266.00K 10-Q · filed 2021-11-10 | $609.00K derived: sum of 2 quarters · filed 2021-11-10 | ||
| 2020-03-31 | $343.00K 10-Q · filed 2021-11-10 | |||
| 2019-12-31 | $2.07M 10-K · filed 2021-03-23 | |||
| 2019-09-30 | $185.00K 10-Q · filed 2020-11-12 | $1.28M derived: sum of 2 quarters · filed 2020-11-12 | $1.74M derived: sum of 3 quarters · filed 2020-11-12 | |
| 2019-06-30 | $1.09M 10-Q · filed 2020-11-12 | $1.55M derived: sum of 2 quarters · filed 2020-11-12 | ||
| 2019-03-31 | $459.00K 10-Q · filed 2020-11-12 | |||
| 2018-12-31 | $2.97M 10-K · filed 2020-03-26 | |||
| 2018-09-30 | $660.00K 10-Q · filed 2019-11-01 | $1.59M derived: sum of 2 quarters · filed 2019-11-01 | $2.36M derived: sum of 3 quarters · filed 2019-11-01 | |
| 2018-06-30 | $933.00K 10-Q · filed 2019-11-01 | $1.70M derived: sum of 2 quarters · filed 2019-11-01 | ||
| 2018-03-31 | $765.00K 10-Q · filed 2019-11-01 | |||
| 2017-12-31 | $2.82M 10-K · filed 2019-02-19 | |||
| 2016-12-31 | $2.83M 10-K · filed 2018-03-13 | |||
| 2015-12-31 | $592.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | -$265.00K derived: sum of 2 quarters · filed 2017-03-10 | $2.48M 10-K · filed 2017-03-10 | |
| 2015-09-30 | -$857.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $1.89M 10-Q · filed 2015-11-12 | ||
| 2015-06-30 | $2.75M 10-Q · filed 2015-08-14 | |||
| 2015-03-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-10 | $612.00K derived: sum of 2 quarters · filed 2015-06-10 | $924.00K derived: sum of 3 quarters · filed 2015-06-10 | $1.08M 10-K · filed 2015-06-10 |
| 2014-12-31 | $312.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-13 | $624.00K derived: sum of 2 quarters · filed 2015-02-13 | $779.00K 10-Q · filed 2015-02-13 | $240.00K 10-K · filed 2016-03-10 |
| 2014-09-30 | $312.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-13 | $467.00K 10-Q · filed 2014-11-13 | ||
| 2014-06-30 | $155.00K 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |